infectious diseases - search results

A new clinical trial, funded by the UK government, will investigate the best gap between the first and second COVID-19 vaccine dose for pregnant women.

Pfizer say they will develop a new COVID vaccine to function as a booster against the Delta variant.

While mRNA is now well-connected to Pfizer or Moderna, saRNA is a more obscure, early-stage vaccine technology - now, scientists in the UK have data suggesting that saRNA COVID vaccines could work well for most people.

Michelle Davis, Head of External Relations at Malaria Consortium, shares with us what we need to know about learning from COVID-19 and the continuing fight against malaria.

The Canadian Institutes of Health Research, part of the Government of Canada, has an Institute of Infection and Immunity. Here, we gain a flavour of what they do.

A new study confirms that antimicrobial resistance increases as people travel internationally, with one scientist commenting that the world faces "a worrisome problem on the horizon".

According to a new study, the antibodies created by the Pfizer vaccine are on average less effective against the Delta variant.

Named after a freedom fighter who spoke up for science and tech, a group of African and international research funders under the OR Tambo Africa Research Chairs Initiative announced Prof Gerald Misinzo and his institution Sokoine University of Agriculture as one of the initiative’s first ten individual research chair holders and host institutions.

Frances Goodrum, Head of External Affairs, Brooke Action for Working Horses and Donkeys, turns our attention to COVID-19 and the urgent case for a greater focus on One Health.

Justin Nogarede, FEPS Digital Policy Analyst, says that while digital tech can’t solve everything, can it solve anything? Read on to find out about the role of digital tech in the COVID-19 pandemic.

Researchers have suggested that data from healthcare workers could be used to rapidly estimate the severity of future viruses.

Physician-researchers reveal that newborns of expectant mothers with COVID-19 can suffer indirect adverse health risks, particularly those of socially vulnerable mothers.

Researchers studied over 30,688 HIV patients across seven Latin American countries - finding that life expectancy has dramatically increased over a period of 14 years.

People who have recovered from COVID-19 may be at risk of developing blood clots due to an overactive immune response, according to a new study.

Uninfected people lived with one infected individual as part of the study - the COVID antibody drug gave them 72% protection against catching the virus themselves.

Several seasoned academic experts describe the move towards strengthening public health surveillance systems in Africa.

The 'London patient' joins the 'Berlin patient' as the second person in history to be cured of HIV, which is achieved via transplant of rare HIV-resistant stem cells.

New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.

New data from the REACT study finds that 14% of the UK population have antibodies against COVID-19 now, but that vaccine hesitancy is currently highest in London.

Carlos Mazorra, Director of Innovation and Enrique Amaré, CEO of SMARTWATER PLANET share with us their thoughts on affordable technology solutions for the aquaculture sector.